General Hospital Of Athens Korgialenio Benakio H.R.C.

Athens 12 trials 6 recruiting

12 Registered trials

6 Currently recruiting

Organisation

General Hospital Of Athens Korgialenio Benakio H.R.C.

Location

Athens, Greece

Identifier

ORG-100042984

Address

Athanasaki 2 Str, 115 26, Greece

Departments

1st Cardiology Clinic
1st Department of Internal Medicine
2nd Department of Cardiology
3rd Department of Internal Medicine
Cardiology Dpt
Department of Endocrinology and Metabolism - Diabetes Center
Department of Neurology
Infectious Diseases Unit
Intensive Care Unit
Nephrology Department

Clinical trials at this site (12)

Search interface

CLARITHROMYCIN TO PREVENT SECONDARY INFECTIONS IN PATIENTS WITH SEPSIS FOLLOWING LOWER RESPIRATORY TRACT INFECTIONS: THE CLASSIFY TRIAL Pending

2025-525058-20-00 Community- acquired pneumonia related sepsis with evide 5
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy and Safety of Fluasterone Buccal Tablet in the Control of Hypergly… Recruiting

2023-508322-10-00 Cushing Syndrome 4 2025-05-02
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
Biomarker-Guided Early Clarithromycin Treatment To Prevent Sepsis Progression In Community-Acquired Pneumonia: The REACT Randomized Clinical… Recruiting

2023-507295-40-00 Community-acquired pneumonia 5 2024-02-12
EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE INTERFERON-GAMMA ENDOTYPE (THE EMBRACE TRIAL) Ended

2024-515255-38-00 SEPSIS 4 2025-03-12
A study to evaluate the efficacy, safety, and tolerability of using an oral once-daily 2 drug regimen compared to an oral once-daily 3 drug … Ended

2023-504993-40-00 Human immunodeficiency virus (HIV) 5 2024-02-14
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended

2022-502962-26-00 Severe infections 5 2023-09-14
rIFN-Gamma 1b in Candidemia Ended

2024-510816-55-00 Candidemia 4 2024-11-08
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24